Literature DB >> 12766188

Intracytoplasmic domains of MHC class II molecules are essential for lipid-raft-dependent signaling.

Stéphane Bécart1, Niclas Setterblad, Suzanne Ostrand-Rosenberg, Santa J Ono, Dominique Charron, Nuala Mooney.   

Abstract

In addition to their role in antigen presentation, major histocompatibility complex (MHC) class II molecules have been widely described as signaling proteins in diverse antigen-presenting cells (APCs) including B cells and dendritic cells. By contrast, little is known of the signaling function of MHC class II molecules expressed in solid tumors. We describe the functional organization and signaling ability of I-Ak expressed in a sarcoma, and report the recruitment of I-Ak to lipid rafts after MHC class II engagement. Lipid raft integrity was required for I-Ak-mediated reorganization of the actin cytoskeleton and translocation of protein kinase C-alpha(PKC-alpha) to the precise site of stimulation via I-Ak. Truncation of the intracytoplasmic domains of I-Ak did not perturb I-Ak recruitment to lipid rafts but abrogated PKC-alpha translocation and actin rearrangement. PKC-alpha was detected in lipid microdomains and enrichment of activated PKC-alphain lipid rafts was induced by I-Ak signaling. Ordering of the molecular events following engagement of the MHC class II molecules revealed that I-Ak recruitment to lipid rafts precedes signaling. This is consistent with the absence of a requirement for the intracytoplasmic tails for localization to lipid rafts. These data reveal that lipid-rich microdomains play a key role in MHC class II-mediated signaling in a solid tumor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766188     DOI: 10.1242/jcs.00449

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  8 in total

Review 1.  A novel, alternative pathway of apoptosis triggered through class II major histocompatibility complex molecules.

Authors:  Zoltan A Nagy; Nuala A Mooney
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

2.  Antigen-independent acquisition of MHC class II molecules by human T lymphocytes.

Authors:  Anita H Undale; Peter J van den Elsen; Esteban Celis
Journal:  Int Immunol       Date:  2004-09-06       Impact factor: 4.823

3.  Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway.

Authors:  Even Walseng; Oddmund Bakke; Paul A Roche
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

4.  MHC Class II and CD9 in human eosinophils localize to detergent-resistant membrane microdomains.

Authors:  Praveen Akuthota; Rossana C N Melo; Lisa A Spencer; Peter F Weller
Journal:  Am J Respir Cell Mol Biol       Date:  2011-09-01       Impact factor: 6.914

5.  The human immunodeficiency virus coat protein gp120 promotes forward trafficking and surface clustering of NMDA receptors in membrane microdomains.

Authors:  Hangxiu Xu; Mihyun Bae; Luis B Tovar-y-Romo; Neha Patel; Veera Venkata Ratnam Bandaru; Daniel Pomerantz; Joseph P Steiner; Norman J Haughey
Journal:  J Neurosci       Date:  2011-11-23       Impact factor: 6.167

6.  The Ia.2 epitope defines a subset of lipid raft-resident MHC class II molecules crucial to effective antigen presentation.

Authors:  Kathleen Busman-Sahay; Elizabeth Sargent; Jonathan A Harton; James R Drake
Journal:  J Immunol       Date:  2011-05-04       Impact factor: 5.422

7.  Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT.

Authors:  M Laura Cremona; Heinrich J G Matthies; Kelvin Pau; Erica Bowton; Nicole Speed; Brandon J Lute; Monique Anderson; Namita Sen; Sabrina D Robertson; Roxanne A Vaughan; James E Rothman; Aurelio Galli; Jonathan A Javitch; Ai Yamamoto
Journal:  Nat Neurosci       Date:  2011-03-13       Impact factor: 24.884

8.  Activation of MyD88 signaling upon staphylococcal enterotoxin binding to MHC class II molecules.

Authors:  Teri L Kissner; Gordon Ruthel; Shahabuddin Alam; Robert G Ulrich; Stefan Fernandez; Kamal U Saikh
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.